World's first medical networking and resource portal

News & Highlights
Please make use of the search function to browse preferred content
Medical News & Updates
Oct 24
Daily dose of Vitamin D can help stave off diabetes
A daily dose of vitamin D can be used in the battle against Type 2 diabetes, experts have revealed.

Researchers are carrying out a major clinical trial to confirm whether taking vitamin D can prevent or delay the condition, the Daily Express reported.

They believe that the "sunshine vitamin" may reduce diabetes risk by 25 per cent.

The study led by Professor Philip Raskin, from UT Southwestern Medical Center in Dallas, Texas, is a four-year trial across America which will track 2,500 people age 30 or older who have pre-diabetes.

They will be given daily doses of vitamin D about five times higher than usually recommended.

Oct 24
Testosterone therapy may cut risk of cardiovascular disease
A new study has suggested that testosterone treatment in hypogonadal (testosterone deficient) men restores normal lipid profiles and may reduce the risk of cardiovascular disease.

In this observational study, researchers from Boston University School of Medicine (BUSM), investigated the effects of testosterone treatment in 255 hypogonadal men between the ages of 33-69 and followed them for a period of five years.

They found that men treated with testosterone therapy experienced a gradual reduction of their total cholesterol, low density lipoprotein cholesterol, triglycerides and increased high density lipoprotein.

"In addition to improving their cholesterol levels, we found that the testosterone treatment resulted in marked reductions in systolic and diastolic blood pressure as well, suggesting amelioration of hypertension," lead author Abdulmaged M. Traish, MBA, PhD, professor of biochemistry and urology as well as Research Director of the Institute of Sexual Medicine at BUSM explained.

Traish found this treatment also reduced fasting blood glucose and hemoglobin A1c, a surrogate marker of hyperglycemia, suggesting that testosterone treatment may improve insulin sensitivity and hyperglycemic control.

It also reduced the levels of inflammatory biomarkers such as C-reactive protein (CRP) and markers of liver dysfunction such as alanine aminotransferase and aspartate aminotransferase, suggesting reduction in the inflammation responses.

The study is published in the International Journal of Clinical Practice.

Oct 23
Breast milk protein that may protect babies from HIV identified
A new research has identified a substance present in breast milk that neutralizes HIV and may protect babies from acquiring HIV from their infected mothers.

Researchers at Duke Medicine have for the first time identified the protein, called Tenascin-C or TNC, which had previously been recognized as playing a role in wound healing, but had not been known to have antimicrobial properties.

The researchers describe how the TNC protein in breast milk binds to and neutralizes the HIV virus, potentially protecting exposed infants who might otherwise become infected from repeated exposures to the virus.

"Even though we have antiretroviral drugs that can work to prevent mother-to-child transmission, not every pregnant woman is being tested for HIV, and less than 60 percent are receiving the prevention drugs, particularly in countries with few resources. So there is still a need for alternative strategies to prevent mother-to-child transmission, which is why this work is important," senior author Sallie Permar, assistant professor of pediatrics, immunology and molecular genetics and microbiology at Duke said.

Permar and colleagues focused on breast milk, which has long been recognized as having some protective quality that inhibits mother-to-child transmission despite multiple daily exposures over months and even years of nursing.

The Duke team screened mature milk samples from uninfected women for neutralizing activity against a panel of HIV strains, confirming that all of the detectable HIV-neutralization activity was contained in the high molecular weight portion. Using a multi-step protein separation process, the researchers narrowed the detectable HIV-neutralization activity to a single protein, and identified it as TNC.

Permar said that TNC is a component of the extracellular matrix that is integral to how tissues hold themselves together. This is a protein involved during wound healing, playing a role in tissue repair. It is also known to be important in fetal development, but its reason for being a component of breast milk or its antiviral properties had never been described.

Permar said TNC would also appear to be inherently safe, since it is a naturally occurring component of breast milk, and it may avoid the problem of HIV resistance to antiretroviral regimens that complicate maternal/infant applications.

The study is published in the journal Proceedings of the National Academy of Sciences.

Oct 23
New Alzheimer's discovery could hold key to preventative treatments for high-risk patients
For years, people with a family history of Alzheimer's disease have shied away from genetic testing, which could reveal that they carry the ApoE4 protein - a genetic risk factor associated with a 10-fold higher chance of developing the incurable neurodegenerative condition.

However, new research has highlighted a potential pathway for early intervention methods that could help those at a high risk for Alzheimer's, making genetic screening for the disease as important as cholesterol tests are to preventing heart disease.

Researchers from The Buck Institute for Research on Aging, an independent research association based in Novato, Calif., have long been interested in discovering why ApoE4 is associated with such a high risk for Alzheimer's disease.

"Why is this the dominant risk factor?" study author Dr. Dale Bredesen, founding CEO of the Buck Institute, told FoxNews.com. "Though people have known this for 20 years, it's never been clear what it is that ApoE4 does to confer such risk."

Prior research had focused on the discovery that ApoE4 appears to affect the clearance of amyloid-beta (A-beta), a plaque that builds up in the brains of patients with Alzheimer's disease. However, Bredesen and his colleagues weren't convinced that this finding told the whole story of why ApoE4 causes Alzheimer's.

"Treating that hasn't worked very well," Bredesen said. "There's an emerging feeling, which we believe, that this is more than just about A-beta."

In a study published in The Proceedings of the National Academy of Sciences, Bredesen and his colleagues analyzed ApoE4 cell cultures and discovered that ApoE4 was also associated with a dramatic reduction in SirT1 - a protein associated with anti-inflammation, anti-aging and longevity.

Bredesen said that as SirT1 decreases, it affects a certain protein crucial to the storage or loss of memories - the amyloid precursor protein (APP).

"You have a molecule called the APP, present in neurons and most cells in your body, and at all times this APP is getting cleaved," Bredesen said. "It turns out there are two alternative patterns. So it is a little bit like how the government can go on shutdown or active. APP can go in the direction of memory or forgetting."

In Alzheimer's, Bredesen says people are on the 'wrong side' of this process - causing them to forget rather than retain memories.

However, by maintaining SirT1 levels, researchers believe they may be able to prevent these proteins from going awry. As a result of their discovery, Bredesen and his colleagues attempted to identify drugs that might be able to maintain levels of SirT1 in ApoE4 cell cultures. So far, they have successfully identified four drugs that seem to be effective - though they have yet to test their findings in humans.

"It gives us a leg up on saying, 'Okay, we can begin to look at how to treat people with ApoE4 even when they're young to make sure they never get Alzheimer's, by affecting that link between ApoE4and Alzheimer's,'" Bredesen said.

Furthermore, Bredesen and his colleagues also performed experiments in which they successfully reinserted SirT1 proteins back into cells already affected by ApoE4. By doing this, they were able to correct the abnormalities present in the cell and return it to a healthy state. This led Bredesen and his colleagues to speculate that treatment might be possible even for those already entering the early stages of Alzheimer's.

"Most people today don't want to know if they have ApoE4 because what can they do about it? This could change the landscape where we say everyone should know, just like with high cholesterol or high blood pressure, because you can do something about it," Bredesen said.

Oct 22
Eating tips to boost fertility revealed
Women watching their weight and closely following a Mediterranean-style diet that is high in vegetables, vegetable oils, fish and beans may boost their chance of becoming pregnant, according to dietitians.

Brooke Schantz, MS, RD, CSSD, LDN, LUHS, said that establishing a healthy eating pattern and weight is a good first step for women who are looking to conceive.

She said that not only will a healthy diet and lifestyle potentially help with fertility, but it also may influence foetal well-being and reduce the risk of complications during pregnancy.

Schantz said that reduced intake of foods with trans and saturated fats while increasing intake of monounsaturated fats, like avocados and olive oil could help women who are looking to conceive.

Another tip was lower intake of animal protein and adding more vegetable protein and fibre to their diet.

She also said that incorporating more vegetarian sources of iron like legumes, tofu, nuts, seeds and whole grains may help women in their endeavour.

Oct 22
Exercise boosts teenagers' brain power: Study
Regular exercise boosts teenagers` school grades -- and particularly helps girls in science, a British study said Tuesday.

The more physically active they were, the better children performed in school, according to findings published online in the British Journal of Sports Medicine.

And "girls` science results seemed to benefit the most", said a press statement.

Physical activity has long been suspected to boost brainpower, but little scientific evidence has existed until now.

For the study, researchers from England, Scotland and the United States measured the level of physical activity among nearly 5,000 11-year-olds who wore a motion-reading "accelerometer" for a week.

Their academic performance in English, maths and science was then assessed at the ages of 11, 13, and 16.

Children who had been more physically active at 11 performed better in all three phases and all three subjects.

Every 17 minutes of exercise per day at the age of 11 led to an additional improvement in marks for boys, and 12 minutes per day for girls by the age of 16, said the findings.

The effect was noticeably large for girls in science classes.

"This is an important finding, especially in light of the current UK and European Commission policy aimed at increasing the number of females in science subjects," wrote the authors.

Worryingly, the researchers observed that aged 11, boys averaged 29 minutes of moderate-to-vigorous exercise per day and girls about 18 -- far lower than the recommended 60 minutes.

"Their findings prompt the authors to speculate on what might happen to academic performance if children increased the amount of moderate-to-vigorous physical activity they did to the recommended 60 minutes," said the statement.

The children had been recruited from a large-scale ongoing project called the Avon Longitudinal Study of Parents and Children (ALSPAC) in southwest England.

The scientists adjusted the results for factors that could influence the findings, like a child`s birthweight, whether their mothers had smoked during pregnancy, weight and socioeconomic background.

Further research was needed to better understand how exercise results in improved marks, said the researchers.

"The findings have implications for public health and education policy by providing schools and parents with a potentially important stake in meaningful and sustained increases in physical activity," they wrote.

Oct 21
How melanoma can become drug resistant
Researchers have claimed that a process involving the phenotypes - the outward, physical appearance based on genetic coding - of tumour cells could change appearance of melanoma tumours by altering the number and type of protein receptors dotting the surface of the individual melanoma cells within the tumour.

Identifying the phenotype patients exhibit may help determine which patients are more likely to benefit from existing medications while also providing an opportunity to create new targeted therapies.

Senior corresponding author Ashani Weeraratna, Ph.D., assistant professor in the Tumour Microenvironment and Metastasis Program of Wistar's NCI-designated Cancer Center, and her team focus on Wnt5A, a Wnt signalling molecule that has been found in increased levels in metastatic melanomas.

In order for Wnt5A to promote the phenotype switch from early in the tumor's formation to the time it becomes metastatic, the tyrosine kinase receptor ROR2 is required. When ROR2 is not present, Wnt5A is unable to promote tutor metastasis.

The only other member of the family that has been identified is ROR1, and this research was done to determine what role ROR1 might play in the progression of melanoma.

The researchers were able to determine that ROR1 inhibited the invasion of melanoma cells, and this receptor was targeted for degradation by Wnt5A and ROR2.

When ROR1 was silenced, the researchers observed that there was an increased rate of invasion of melanoma cells both in vitro and in vivo. The researchers also found that hypoxia - areas of low oxygen supply in the tumor - is able to induce a switch from ROR1 to ROR2 and results in an increase in levels of Wnt5A, suggesting the switch from a non-invasive ROR1-positive phenotype to an invasive ROR2-positive phenotype occurs when the tumor is exposed to hypoxic conditions.

The researchers also found that a protein HIF1a is required to increase the Wnt5A expressed. When HIF1a was removed, ROR2 was decreased, indicating that the upregulation of ROR2 via HIF1a requires Wnt5A.

The findings have been published online in the journal Cancer Discovery.

Oct 21
Treatment of hypothyroidism not linked to weight loss
Decreased thyroid function, or hypothyroidism, is commonly associated with weight gain, but a new study has found that effective treatment with levothyroxine (LT4) to restore normal thyroid hormone levels is not associated with clinically significant weight loss in most people.

Researchers SY Lee, LE Braverman, and EN Pearce describe the retrospective review of patients with newly diagnosed primary hypothyroidism over an 8-year period, not caused by thyroid cancer or other forms of disease or associated with pregnancy or use of prescription weight loss medication.

It was found that about 52 percent of the patients lost weight up to 24 months after initiation of treatment with LT4.

Ronald J. Koenig , M.D., Ph.D, Professor, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, said because obesity and hypothyroidism are very common, there are many patients who have both conditions.

Koenig said that these patients and sometimes their physicians often assume the hypothyroidism is causing the obesity even though this may not be the case.

This study is important because it shows, unfortunately, that only about half of hypothyroid patients lose weight after the successful treatment of their hypothyroidism.

The study will be presented at the 83rd Annual Meeting of the American Thyroid Association, in San Juan, Puerto Rico.

Oct 19
Low back pain among women tied to flat feet: Study
Women who walk with flat feet are 50 percent more likely than those with normal or high arches to have low back pain, a new study suggests.

"The key takeaway from the study is that if women have low back pain, it may not be just the back," said senior author Marian Hannan of the Institute for Aging Research at Hebrew SeniorLife in Boston.

"It turns out that feet are important for the back."

Past research has hinted that low back pain, which affects roughly one in five people worldwide, could be related to the shape of the foot's arch in the standing position.

This study, published in Rheumatology, focused on the arch while a person walked.

Among 1,930 men and women recruited from Framingham, Massachusetts, pronated feet - which tend to roll inward as a person walks - were linked to lower back pain in women only.

"There has been only weak correlation between pronated feet and low back pain so I was happy to see some evidence of this in the study," said Christopher Kevin Wong.

He is an associate professor of rehabilitation and regenerative medicine at Columbia University in New York City and was not involved with the current study.

For their study, Hannan and her colleagues measured each person's arch in the standing position. Then participants walked across a mat with embedded sensors to measure pressure from the heel to the tip of the foot while walking.

"It's a method that shows promise, and will need to be validated against other measures of motion analysis," Wong told Reuters Health.

For example, another method includes marking a person's leg with ink at the joints in order to detect under- or over-pronation movements.

Women in the study were in their 60s, on average. About 38 percent overall reported having low back pain.

Dr. Stephen Pinney, an orthopedic surgeon at St. Mary's Medical Center in San Francisco, called the size of the study "impressive."

He told Reuters Health future studies should follow participants with different arches forward in time to confirm these findings. Research should also determine what effect, if any, interventions such as orthotics might have on who develops back pain.

"We've known that putting a patient in a foot cast after surgery, for example, can lead to lower back pain because this creates asymmetric forces on the back," said Pinney, who didn't participate in the new research.

Hannan said the body may use other muscles to help make up for flat feet when a person walks, which could explain the link to back pain.

Standing and walking use the foot in different ways. Both a flat foot in standing position and a pronated foot walking could be something to consider during a doctor's visit, Hannan said.

She and her team suggested reasons why women could be more affected by flat feet while walking than men.

For example, women's pelvic bones are wider and not as flexible as men's. In general, women rotate their hips more than men while walking. Women also move their upper bodies more than men when they walk.

"Women probably don't know if their foot function contributes to low back pain, but they can find out about it," Hannan told Reuters Health.

She suggested people with low back pain visit a doctor or physical therapist.

One simple trick to strengthen muscles in the feet is to lay a towel on a flat surface and then scrunch the toes together in order to pick up the towel and lower it back down. Foot orthotics are another option.

"Once you have back pain, you'll want to do core muscle exercises and perhaps take anti-inflammatory medication, but anything that is contributing to asymmetry - you will also want to address that," Pinney said.

"There are a bunch of different reasons for getting low back pain, and this adds another category for people to consider," he said.

Oct 19
Good night's sleep cleans out gunk in brain, study shows
When we sleep, our brains get rid of gunk that builds up while we're awake, suggests a study that may provide new clues to treat Alzheimer's disease and other disorders.

This cleaning was detected in the brains of sleeping mice, but scientists said there's reason to think it happens in people too.

If so, the finding may mean that for people with dementia and other mind disorders, "sleep would perhaps be even more important in slowing the progression of further damage," Dr. Clete Kushida, medical director of the Stanford Sleep Medicine Center, said in an email.

Kushida did not participate in the study, which appears in Friday's issue of the journal Science.

People who don't get enough shut-eye have trouble learning and making decisions, and are slower to react. But despite decades of research, scientists can't agree on the basic purpose of sleep. Reasons range from processing memory, saving energy to regulating the body.

The latest work, led by scientists at the University of Rochester Medical Center, adds fresh evidence to a long-standing view: When we close our eyes, our brains go on a cleaning spree.

The team previously found a plumbing network in mouse brains that flushes out cellular waste. For the new study, the scientists injected the brains of mice with beta-amyloid, a substance that builds up in Alzheimer's disease, and followed its movement. They determined that it was removed faster from the brains of sleeping mice than awake mice.

The team also noticed that brain cells tend to shrink during sleep, which widens the space between the cells. This allows waste to pass through that space more easily.

Though the work involved mouse brains, lead researcher Dr. Maiken Nedergaard said this plumbing system also exists in dogs and baboons, and it's logical to think that the human brain also clears away toxic substances. Nedergaard said the next step is to look for the process in human brains.

In an accompanying editorial, neuroscientist Suzana Herculano-Houzel of the Federal University of Rio de Janeiro said scientists have recently taken a heightened interest in the spaces between brain cells, where junk is flushed out.

It's becoming clearer that "sleep is likely to be a brain state in which several important housekeeping functions take place," she said in an email.

The study was funded by the National Institute of Neurological Disorders and Stroke. In a statement, program director Jim Koenig said the finding could lead to new approaches for treating a range of brain diseases.

Browse Archive